Question 1

What is Emergent BioSolutions?

Accepted Answer

Emergent BioSolutions is a Company.

Question 2

How often does Emergent BioSolutions appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Emergent BioSolutions first tracked by Ergen?

Accepted Answer

First tracked on Apr 29, 2026.

Question 4

When was Emergent BioSolutions last mentioned in news?

Accepted Answer

Last active on Aug 12, 2026.

Question 5

What is Emergent BioSolutions's current news sentiment?

Accepted Answer

Aggregate sentiment score: -20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Emergent BioSolutions in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Emergent BioSolutions?

Accepted Answer

Emergent BioSolutions securities fraud investigation (Aug 10, 2026, 6 articles).

Question 8

How did the "Emergent BioSolutions securities fraud investigation" event impact Emergent BioSolutions?

Accepted Answer

Emergent BioSolutions is the subject of the investigation. The company reduced its FY2026 revenue and EBITDA guidance and recorded a $191.3 million impairment on Naloxone, leading to a sharp stock decline and potential legal liabilities.

Question 9

How did the "Davis Schneider, Emergent BioSolutions Partner" event impact Emergent BioSolutions?

Accepted Answer

Emergent BioSolutions, the manufacturer of Narcan (naloxone) nasal spray, partnered with Davis Schneider to promote awareness and availability of naloxone, potentially increasing its market reach and public perception.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.